MASERATI, RENATO
 Distribuzione geografica
Continente #
NA - Nord America 419
EU - Europa 398
AS - Asia 182
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.003
Nazione #
US - Stati Uniti d'America 413
IT - Italia 164
IE - Irlanda 135
CN - Cina 131
SG - Singapore 38
DE - Germania 32
FI - Finlandia 32
SE - Svezia 9
FR - Francia 8
BE - Belgio 6
CA - Canada 6
IN - India 5
CZ - Repubblica Ceca 3
GB - Regno Unito 3
IR - Iran 3
JP - Giappone 3
NL - Olanda 3
LK - Sri Lanka 2
A2 - ???statistics.table.value.countryCode.A2??? 1
ES - Italia 1
EU - Europa 1
MA - Marocco 1
MU - Mauritius 1
PL - Polonia 1
RO - Romania 1
Totale 1.003
Città #
Dublin 135
Chandler 116
Milan 41
Boardman 38
Helsinki 30
Pavia 28
New York 26
Ashburn 24
Nanjing 24
Singapore 23
Princeton 21
Shanghai 19
Lawrence 17
Beijing 13
Medford 12
Munich 12
Vicenza 11
Wilmington 11
Nanchang 10
Changsha 9
Hebei 8
Tianjin 8
Jiaxing 7
Shenyang 7
Paris 6
Brescia 5
Brussels 5
Hangzhou 5
Los Angeles 5
Piscataway 5
Pune 5
Toronto 5
Ann Arbor 4
Corsico 4
Falkenstein 4
Jacksonville 4
Motta Visconti 4
Seattle 4
Turin 4
Cascina 3
Chicago 3
Ferrara di Monte Baldo 3
Frankfurt am Main 3
Laives 3
Magenta 3
Olomouc 3
Tokyo 3
Verona 3
Vigevano 3
Amsterdam 2
Andover 2
Bereguardo 2
Borås 2
Buccinasco 2
Colombo 2
Como 2
Mariglianella 2
Parma 2
Rho 2
Washington 2
Baoding 1
Dallas 1
Des Moines 1
Fairfield 1
Fayetteville 1
Guangzhou 1
Henderson 1
Hengyang 1
Jinan 1
Jining 1
Leawood 1
London 1
Luoyang 1
Naples 1
Ningbo 1
Orange 1
Ottawa 1
Padova 1
Pompei 1
Putian 1
Redmond 1
Redwood City 1
Rome 1
Sacramento 1
San Genesio ed Uniti 1
Shenzhen 1
Shijiazhuang 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Triuggio 1
Weimar 1
Xiangfan 1
Zanjan 1
Totale 805
Nome #
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 68
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 63
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 63
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 61
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 59
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs 58
HIV-RELATED ACUTE INFLAMMATORY LEUKOENCEPHALOPATHY OF UNDETERMINED ORIGIN: SYSTEMATIC REVIEW OF THE LITERATURE 58
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 55
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 51
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 49
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy 49
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 48
Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting 46
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 45
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 43
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 42
Denosumab for the treatment of HIV-associated osteoporosis with fractures in a premenopausal woman 40
High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk 39
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit 37
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 26
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy 25
Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study 19
Totale 1.044
Categoria #
all - tutte 7.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 1 1 0 7 2 3 0
2020/202156 0 0 29 7 4 1 4 2 4 2 3 0
2021/2022103 7 5 4 1 2 2 3 7 3 5 10 54
2022/2023372 25 35 5 21 24 33 0 12 161 2 46 8
2023/2024228 20 25 8 8 47 42 7 11 8 7 17 28
2024/2025163 18 37 8 34 17 49 0 0 0 0 0 0
Totale 1.044